VC-backed Sensei Biotherapeutics raises $133m for IPO
Sensei Biotherapeutics, a developer of next-generation cancer treatments, has raised about $133 million for its IPO after pricing its over 7 million shares at $10 per share.
Sensei Biotherapeutics, a developer of next-generation cancer treatments, has raised about $133 million for its IPO after pricing its over 7 million shares at $10 per share.
Copyright PEI Media
Not for publication, email or dissemination